Neurocrine Biosciences NBIX
NASDAQ NBIX
$153.97 -1.57 (-1.01%)
At close: Aug 20, 2026 · 2:05 PM UTC

Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (1y) (2012 - 2026)

Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -83.16%
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 128.45%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -97.39%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -8.29%
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 101.66%
Mar 31, 2026 -87.09%
Dec 31, 2025 -17.97%
Sep 30, 2025 -92.49%
Jun 30, 2025 -40.06%
Mar 31, 2025 -84.41%
Dec 31, 2024 -167.48%
Sep 30, 2024 -87.64%
Jun 30, 2024 -87.61%
Mar 31, 2024 338.05%
Dec 31, 2023 150.88%
Sep 30, 2023 -43.24%
Jun 30, 2023 -87.61%
Mar 31, 2023 -982.36%
Dec 31, 2022 -235.71%
Sep 30, 2022 985.17%
Jun 30, 2022 145.47%
Mar 31, 2022 -84.25%
Dec 31, 2021 -2.65%
Sep 30, 2021 2,019.23%